Andromeda Metals (ADN) H2 2025 earnings summary

Executive summary

• Advanced the Great White Project (GWP) toward a final investment decision, securing four binding offtake agreements across key global markets, validating product quality and supporting funding strategy.

• Achieved credit approval for a $75 million debt facility from Merricks Capital, with ongoing efforts to secure remaining equity funding.

• Implemented cost-saving measures, including director fee reductions, part-time staffing, and divestment of non-core assets, conserving over $610,000 in cash.

• Significant board and management renewal, with new directors bringing expertise in industrial minerals and global markets.

Financial highlights

• FY25 income was $760,443, a 26.2% decrease year-over-year; net loss after tax was $6,038,438, a 16.9% improvement from the prior year.

• Earnings per share loss improved to 0.18 cents from 0.23 cents in FY24.

• Cash and cash equivalents at year-end were $7,141,892, up 31.4% from the previous year.

• Two capital raisings in FY25 raised $3.82 million and $5 million, with potential for an additional $11.6 million if options are exercised.

Outlook and guidance

• Focus remains on securing full funding and commencing construction for GWP Stage 1A+.

• HPA Project to progress to next phase, including pilot-scale test work and pre-feasibility study, subject to funding.

• Anticipates first commercial HPA product within two years post-investment decision, pending successful studies and funding.